These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36806995)

  • 1. Clinical phenotypes of euthyroid, hyperthyroid, and hypothyroid thyroid-associated ophthalmopathy.
    Yang M; Wang Y; Du B; He W
    Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):1995-2002. PubMed ID: 36806995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, Phenotype, and Psychosocial Well-Being in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy.
    Ponto KA; Binder H; Diana T; Matheis N; Otto AF; Pitz S; Pfeiffer N; Kahaly GJ
    Thyroid; 2015 Aug; 25(8):942-8. PubMed ID: 26244413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypo vs. hyperthyroid eye disease: is there any difference?
    Eshraghi B; Pourazizi M; Abbasi M; Mohammadbeigy I
    BMC Ophthalmol; 2023 Feb; 23(1):58. PubMed ID: 36765316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases.
    Du B; Wang Y; Yang M; He W
    Eye (Lond); 2021 Aug; 35(8):2294-2301. PubMed ID: 33139874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients.
    Jang SY; Lee SY; Lee EJ; Yoon JS
    Eye (Lond); 2012 Sep; 26(9):1263-9. PubMed ID: 22744391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.
    Eckstein AK; Lösch C; Glowacka D; Schott M; Mann K; Esser J; Morgenthaler NG
    Br J Ophthalmol; 2009 Aug; 93(8):1052-6. PubMed ID: 19221109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile of thyroid eye disease and factors predictive of disease severity.
    Muralidhar A; Das S; Tiple S
    Indian J Ophthalmol; 2020 Aug; 68(8):1629-1634. PubMed ID: 32709794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.
    Sieminska L; Niedziolka D; Pillich A; Kos-Kudla B; Marek B; Nowak M; Borgiel-Marek H
    J Endocrinol Invest; 2008 Sep; 31(9):745-9. PubMed ID: 18997483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
    Träisk F; Tallstedt L; Abraham-Nordling M; Andersson T; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Ponjavic V; Taube A; Törring O; Wallin G; Asman P; Lundell G;
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3700-7. PubMed ID: 19723755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of thyroid hormone status on selected antioxidant parameters in patients with Graves' disease and active thyroid-associated orbitopathy.
    Londzin-Olesik M; Kos-Kudła B; Nowak A; Wielkoszyński T; Nowak M
    Endokrynol Pol; 2020; 71(5):418-424. PubMed ID: 32797475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Typical graves' ophthalmopathy in primary hypothyroidism.
    Kiran Z; Rashid O; Islam N
    J Pak Med Assoc; 2017 Jul; 67(7):1104-1106. PubMed ID: 28770897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term multidisciplinary follow-up of unilateral thyroid-associated orbitopathy.
    Daumerie Ch; Duprez T; Boschi A
    Eur J Intern Med; 2008 Nov; 19(7):531-6. PubMed ID: 19013383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.
    Salvi M; Vannucchi G; Campi I; Currò N; Dazzi D; Simonetta S; Bonara P; Rossi S; Sina C; Guastella C; Ratiglia R; Beck-Peccoz P
    Eur J Endocrinol; 2007 Jan; 156(1):33-40. PubMed ID: 17218723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthyroid vs hypothyroid eye disease: the same severity and activity.
    Kashkouli MB; Pakdel F; Kiavash V; Heidari I; Heirati A; Jam S
    Eye (Lond); 2011 Nov; 25(11):1442-6. PubMed ID: 21818129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1) in patients witt Graves' disease and thyroid associated orbitopathy].
    Kulig G; Pilarska K; Kulig J
    Przegl Lek; 2004; 61(12):1319-24. PubMed ID: 15850321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of Immulite® TSI immunoassay for thyroid-associated orbitopathy in patients with recently diagnosed Graves' hyperthyroidism.
    Thia B; McGuinness MB; Ebeling PR; Khong JJ
    Int Ophthalmol; 2022 Mar; 42(3):863-870. PubMed ID: 34613563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of 403 cases of thyroid associated ophthalmopathy].
    Wang YJ; He WM
    Zhonghua Yan Ke Za Zhi; 2013 Aug; 49(8):685-90. PubMed ID: 24246805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 339 cases of thyroid-associated ophthalmopathy].
    He JF; Wu ZY; Yang HS; Yan JH; Mao YX; Chen ZC; Ai SM
    Zhonghua Yan Ke Za Zhi; 2004 Jun; 40(6):368-72. PubMed ID: 15312599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and gender influence on clinical manifestations of thyroid-associated ophthalmopathy: a case series of 2479 Chinese patients.
    Yang M; He W
    Front Endocrinol (Lausanne); 2024; 15():1434155. PubMed ID: 39421533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are ethnicity, social grade, and social deprivation associated with severity of thyroid-associated ophthalmopathy?
    Edmunds MR; Huntbach JA; Durrani OM
    Ophthalmic Plast Reconstr Surg; 2014; 30(3):241-5. PubMed ID: 24608325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.